Page 7 - Base Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Exact Sciences (EXAS) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Exact Sciences (NASDAQ: EXAS) Thank you. Please, go ahead, sir. Erik Holznecht -- Investor Relations Thank you, Kathy, and thank all of you for joining us for the Exact Sciences fourth-quarter 2020 conference call. On the call, today are Kevin Conroy, the company's chairman and CEO; and Jeff Elliott, our chief financial officer. Exact Sciences issued a news release earlier this afternoon detailing our fourth-quarter financial results. T...

Due to an accounting charge taken because of an acquisition, the company was deep in the red on the bottom line.

Find the latest Exact Sciences Corporation (EXAS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

Exact Sciences Announces Fourth Quarter 2020 Results News provided by Share this article Share this article MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and $1,491.4 million for the full year ended Dec. 31, 2020. "Exact Sciences finished another transformative year by delivering strong fourth quarter results against a challenging backdrop because of the pandemic," said Kevin Conroy, chairman and CEO of Exact Sciences. "We are a leader in cancer...

Shares of Exact Sciences (NASDAQ:EXAS) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose ...